共 50 条
- [25] RISKS VS BENEFITS IN CANCER DRUG DEVELOPMENT FOOD DRUG COSMETIC LAW JOURNAL, 1968, 23 (01): : 29 - 31
- [27] Time-Efficacy in SMA Type 1 and 2 Cases Treated with Nusinersen BALNEO AND PRM RESEARCH JOURNAL, 2023, 14 (02):
- [28] Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis Orphanet Journal of Rare Diseases, 16